Your browser doesn't support javascript.
loading
Predictors of Severity of Influenza-Related Hospitalizations: Results From the Global Influenza Hospital Surveillance Network (GIHSN).
Cohen, Lily E; Hansen, Chelsea L; Andrew, Melissa K; McNeil, Shelly A; Vanhems, Philippe; Kyncl, Jan; Domingo, Javier Díez; Zhang, Tao; Dbaibo, Ghassan; Laguna-Torres, Victor Alberto; Draganescu, Anca; Baumeister, Elsa; Gomez, Doris; Raboni, Sonia M; Giamberardino, Heloisa I G; Nunes, Marta C; Burtseva, Elena; Sominina, Anna; Medic, Snezana; Coulibaly, Daouda; Salah, Afif Ben; Otieno, Nancy A; Koul, Parvaiz A; Unal, Serhat; Tanriover, Mine Durusu; Mazur, Marie; Bresee, Joseph; Viboud, Cecile; Chaves, Sandra S.
Afiliação
  • Cohen LE; Ready2Respond p/o The Task Force for Global Health, Decatur, Georgia, USA.
  • Hansen CL; Department of Medical Education, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Andrew MK; Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, Maryland, USA.
  • McNeil SA; Brotman Baty Institute, University of Washington, Seattle, Washington, USA.
  • Vanhems P; PandemiX Center, Department of Science & Environment, Roskilde University, Denmark.
  • Kyncl J; Canadian Center for Vaccinology, IWK Health Centre and Nova Scotia Health, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Domingo JD; Canadian Center for Vaccinology, IWK Health Centre and Nova Scotia Health, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Zhang T; Hôpital Edouard Herriot, Lyon, France.
  • Dbaibo G; Department of Infectious Diseases Epidemiology, National Institute of Public Health, Prague, Czech Republic.
  • Laguna-Torres VA; Department of Epidemiology and Biostatistics, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Draganescu A; Fundación Para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.
  • Baumeister E; School of Public Health, Fudan University, Shanghai, China.
  • Gomez D; Center for Infectious Diseases Research, American University of Beirut, Beirut, Lebanon.
  • Raboni SM; Clínica Internacional, Instituto de Medicina Tropical Universidad Nacional Mayor de San Marcos, Lima, Peru.
  • Giamberardino HIG; National Institute for Infectious Diseases "Prof Dr Matei Bals", Bucharest, Romania.
  • Nunes MC; Respiratory Virus Laboratory, Virology Department, INEI-ANLIS, Buenos Aires, Argentina.
  • Burtseva E; Grupo de Investigación UNIMOL, Facultad de Medicina, Universidad de Cartagena, Cartagena de Indias, Colombia.
  • Sominina A; Virology Laboratory, Infectious Diseases Division, Universidade Federal do Paraná, Hospital Pequeno Principe, Curitiba, Paraná, Brazil.
  • Medic S; Virology Laboratory, Infectious Diseases Division, Universidade Federal do Paraná, Hospital Pequeno Principe, Curitiba, Paraná, Brazil.
  • Coulibaly D; South African Medical Research Council, Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Salah AB; Department of Science and Technology/National Research Foundation, South African Research Chair Initiative in Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Otieno NA; Gamaleya Federal Research Center for Epidemiology and Microbiology, Ministry of Health of Russian Federation, Moscow, Russia.
  • Koul PA; Smorodintsev Research Institute of Influenza, St Petersburg, Russia.
  • Unal S; Institute for Public Health of Vojvodina, Novi Sad, Serbia.
  • Tanriover MD; Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia.
  • Mazur M; National Institute of Public Hygiene, Abidjan, Côte d'Ivoire.
  • Bresee J; Institut Pasteur de Tunis, Tunis, Tunisia.
  • Viboud C; Arabian Gulf University, Manama, Bahrain.
  • Chaves SS; Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.
J Infect Dis ; 229(4): 999-1009, 2024 Apr 12.
Article em En | MEDLINE | ID: mdl-37527470
BACKGROUND: The Global Influenza Hospital Surveillance Network (GIHSN) has since 2012 provided patient-level data on severe influenza-like-illnesses from >100 participating clinical sites worldwide based on a core protocol and consistent case definitions. METHODS: We used multivariable logistic regression to assess the risk of intensive care unit admission, mechanical ventilation, and in-hospital death among hospitalized patients with influenza and explored the role of patient-level covariates and country income level. RESULTS: The data set included 73 121 patients hospitalized with respiratory illness in 22 countries, including 15 660 with laboratory-confirmed influenza. After adjusting for patient-level covariates we found a 7-fold increase in the risk of influenza-related intensive care unit admission in lower middle-income countries (LMICs), compared with high-income countries (P = .01). The risk of mechanical ventilation and in-hospital death also increased by 4-fold in LMICs, though these differences were not statistically significant. We also find that influenza mortality increased significantly with older age and number of comorbid conditions. Across all severity outcomes studied and after controlling for patient characteristics, infection with influenza A/H1N1pdm09 was more severe than with A/H3N2. CONCLUSIONS: Our study provides new information on influenza severity in underresourced populations, particularly those in LMICs.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Influenza Humana Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Influenza Humana Idioma: En Ano de publicação: 2024 Tipo de documento: Article